Table 3.
Types of AE categories in readmission and no readmission group
| Study population | All individuals | Younger individuals (<65 years) | Older individuals (≥65 years) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N (%) or median (range) | Total study population | Readmission group | No readmission group | p value* | Readmission group | No readmission group | p value* | Readmission group | No readmission group | p value* |
| N = 333 | N = 65 (19.5) | N = 268 (80.5) | N = 33 (21.0) | N = 124 (79.0) | N = 32 (18.2) | N = 144 (81.8) | ||||
| Type of AE as reason for index admission | ||||||||||
| Medication-related | 179 (53.8) | 27 (41.5) | 152 (56.7) | 0.03 | 10 (30.3) | 61 (49.2) | 0.05 | 17 (53.1) | 91 (63.2) | 0.29 |
| Chemotherapy-related | 74 (22.2) | 21 (32.3) | 53 (19.8) | 0.03 | 15 (45.5) | 33 (26.6) | 0.04 | 6 (18.8) | 20 (13.9) | 0.58 |
| Procedure-related | 50 (15.0) | 15 (23.1) | 34 (13.1) | 0.04 | 7 (21.2) | 15 (12.1) | 0.18 | 8 (25.0) | 20 (13.9) | 0.18 |
| Diabetes mellitus-related | 29 (8.7) | 2 (3.1) | 27 (10.1) | 0.09 | 1 (3.0) | 15 (12.1) | 0.13 | 1 (3.1) | 12 (8.3) | 0.47 |
| Other | 1 (0.3) | 0 | 1 (0.4) | 1.0 | 0 | 0 | NA | 0 | 1 (0.7) | 1.0 |
Numbers in italic show significant differences
AE adverse event
* p values are given for statistical test between the readmission and no readmission groups